EUVIMEDEUVIMED entdecken
Crossref

COMPARATIVE ANALYSIS OF THE EFFECTIVENESS OF BLEOMYCIN AND ETHOXYSCLEROL IN THE TREATMENT OF VENOUS MALFORMATIONS: Experience of the A.N. Syzganov National Scientific Center of Surgery

Alisher Kozhamkul, Yerzhan Abilkhanov, M Zhakubayev, Alexander Sapunov, A Berkinbay, A Saduakas, T Demeuov

BULLETIN OF SURGERY OF KAZAKHSTAN · 2025

DOI: 10.35805/bsk2025iv006 ↗

Kurz gefasst

Fachartikel in der Zeitschrift BULLETIN OF SURGERY OF KAZAKHSTAN, 2025. Verfasst von Alisher Kozhamkul und 6 weiteren Autor:innen. Die Arbeit nennt 23 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Venous malformations represent congenital slow-flow vascular anomalies accounting for 45–60% of all vascular malformations. They arise from developmental defects of venous channels and are frequently associated with chronic pain, swelling, cosmetic deformity, and functional limitations. Materials and Methods: A retrospective analysis included 40 patients with venous malformations treated at the A.N. Syzganov National Scientific Center of Surgery (2019–2024). Patients underwent two ultrasound-guided sclerotherapy sessions and were assigned to bleomycin (n = 20) or ethoxysclerol (n = 20). Outcomes included lesion-volume reduction on magnite resonance / ultrasound and changes in EQ-5D-5L and EQ-VAS scores.

Results

Mean venous malformations volume reduction after two sessions was 32.2 ± 10.1% with bleomycin and 29.6 ± 12.3% with ethoxysclerol (p = 0.42). EQ-5D-5L improved by +0.20 and +0.16, respectively (p = 0.40). Although baseline EQ-VAS was higher in the ethoxysclerol group, the gain was greater with bleomycin (+13.2 vs. +7.5; p = 0.06). No severe complications were registered; mild reactions occurred in 27.5%. Predictors of ≥50% regression were baseline lesion volume < 35 cm³ (OR = 2.8; p = 0.02) and body mass index < 27 kg/m² (OR = 2.3; p = 0.04).

Conclusion

Both sclerosants are effective and safe for treating venous malformations. Bleomycin showed a trend toward greater subjective improvement and fewer additional procedures. Personalized agent selection should consider lesion volume, body mass index, and individual clinical features.

Zitieren

APA

Kozhamkul, A., Abilkhanov, Y., Zhakubayev, M., Sapunov, A., Berkinbay, A., Saduakas, A., & Demeuov, T. (2025). COMPARATIVE ANALYSIS OF THE EFFECTIVENESS OF BLEOMYCIN AND ETHOXYSCLEROL IN THE TREATMENT OF VENOUS MALFORMATIONS: Experience of the A.N. Syzganov National Scientific Center of Surgery. BULLETIN OF SURGERY OF KAZAKHSTAN. https://doi.org/10.35805/bsk2025iv006

Vancouver

Kozhamkul A, Abilkhanov Y, Zhakubayev M, Sapunov A, Berkinbay A, Saduakas A, et al. COMPARATIVE ANALYSIS OF THE EFFECTIVENESS OF BLEOMYCIN AND ETHOXYSCLEROL IN THE TREATMENT OF VENOUS MALFORMATIONS: Experience of the A.N. Syzganov National Scientific Center of Surgery. BULLETIN OF SURGERY OF KAZAKHSTAN. 2025. doi:10.35805/bsk2025iv006

BibTeX
@article{Kozhamkul2025,
  author = {Kozhamkul, Alisher and Abilkhanov, Yerzhan and Zhakubayev, M and Sapunov, Alexander and Berkinbay, A and Saduakas, A and Demeuov, T},
  title = {COMPARATIVE ANALYSIS OF THE EFFECTIVENESS OF BLEOMYCIN AND ETHOXYSCLEROL IN THE TREATMENT OF VENOUS MALFORMATIONS: Experience of the A.N. Syzganov National Scientific Center of Surgery},
  journal = {BULLETIN OF SURGERY OF KAZAKHSTAN},
  year = {2025},
  doi = {10.35805/bsk2025iv006}
}
Kostenlos starten →